Cargando…
Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
BACKGROUND: In high-burden settings, guidelines recommend antibiotic treatment for all suspected group A Streptococcus (GAS) infections to prevent rheumatic fever and poststreptococcal glomerulonephritis. Highly sensitive rapid GAS tests could reduce unnecessary antibiotic use in these settings. MET...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469435/ https://www.ncbi.nlm.nih.gov/pubmed/31011589 http://dx.doi.org/10.1093/ofid/ofz097 |
_version_ | 1783411641949356032 |
---|---|
author | Ralph, Anna P Holt, Deborah C Islam, Sharifun Osowicki, Joshua Carroll, David E Tong, Steven Y C Bowen, Asha C |
author_facet | Ralph, Anna P Holt, Deborah C Islam, Sharifun Osowicki, Joshua Carroll, David E Tong, Steven Y C Bowen, Asha C |
author_sort | Ralph, Anna P |
collection | PubMed |
description | BACKGROUND: In high-burden settings, guidelines recommend antibiotic treatment for all suspected group A Streptococcus (GAS) infections to prevent rheumatic fever and poststreptococcal glomerulonephritis. Highly sensitive rapid GAS tests could reduce unnecessary antibiotic use in these settings. METHODS: This was a prospective study of the Xpert Xpress Strep A (Cepheid) molecular test compared with culture of throat swab samples collected at a referral hospital in northern Australia. Demographic and clinical data and results of streptococcal serology and culture were collected. RESULTS: Of 164 throat swab samples, 145 (88%) were eligible for inclusion; 49 (34%) were molecular test positive and 24 (17%) were culture positive for GAS. The sensitivity, specificity, and positive and negative predictive values for the molecular test versus culture were 100.0%, 79.3%, 48.8%, and 100.0%, respectively. Among 25 samples testing positive with the molecular test and negative with culture, group C or G streptococci were cultured in 2, and a plausible clinical explanation, such as pharyngotonsillitis, or rheumatic fever with positive results of streptococcal serology, was apparent in 19 instances. In 25 patients with rheumatic fever or poststreptococcal glomerulonephritis diagnoses, molecular testing nearly trebled the detection of GAS in throat swab samples, from 3 (12%) detected with culture to 8 (32%) detected with molecular testing. Reasons for “false-positive” molecular test results could include the presence of GAS below the threshold of culture detection or persistence of nonviable organisms after infection. CONCLUSION: Implementation of molecular testing could improve antibiotic use in this high-burden setting. The incremental yield in poststreptococcal syndromes, by which time cultures are negative, has high potential in the diagnostic workup of autoimmune poststreptococcal syndromes and warrants further investigation. |
format | Online Article Text |
id | pubmed-6469435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64694352019-04-22 Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study Ralph, Anna P Holt, Deborah C Islam, Sharifun Osowicki, Joshua Carroll, David E Tong, Steven Y C Bowen, Asha C Open Forum Infect Dis Major Article BACKGROUND: In high-burden settings, guidelines recommend antibiotic treatment for all suspected group A Streptococcus (GAS) infections to prevent rheumatic fever and poststreptococcal glomerulonephritis. Highly sensitive rapid GAS tests could reduce unnecessary antibiotic use in these settings. METHODS: This was a prospective study of the Xpert Xpress Strep A (Cepheid) molecular test compared with culture of throat swab samples collected at a referral hospital in northern Australia. Demographic and clinical data and results of streptococcal serology and culture were collected. RESULTS: Of 164 throat swab samples, 145 (88%) were eligible for inclusion; 49 (34%) were molecular test positive and 24 (17%) were culture positive for GAS. The sensitivity, specificity, and positive and negative predictive values for the molecular test versus culture were 100.0%, 79.3%, 48.8%, and 100.0%, respectively. Among 25 samples testing positive with the molecular test and negative with culture, group C or G streptococci were cultured in 2, and a plausible clinical explanation, such as pharyngotonsillitis, or rheumatic fever with positive results of streptococcal serology, was apparent in 19 instances. In 25 patients with rheumatic fever or poststreptococcal glomerulonephritis diagnoses, molecular testing nearly trebled the detection of GAS in throat swab samples, from 3 (12%) detected with culture to 8 (32%) detected with molecular testing. Reasons for “false-positive” molecular test results could include the presence of GAS below the threshold of culture detection or persistence of nonviable organisms after infection. CONCLUSION: Implementation of molecular testing could improve antibiotic use in this high-burden setting. The incremental yield in poststreptococcal syndromes, by which time cultures are negative, has high potential in the diagnostic workup of autoimmune poststreptococcal syndromes and warrants further investigation. Oxford University Press 2019-02-26 /pmc/articles/PMC6469435/ /pubmed/31011589 http://dx.doi.org/10.1093/ofid/ofz097 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Major Article Ralph, Anna P Holt, Deborah C Islam, Sharifun Osowicki, Joshua Carroll, David E Tong, Steven Y C Bowen, Asha C Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study |
title | Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study |
title_full | Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study |
title_fullStr | Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study |
title_full_unstemmed | Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study |
title_short | Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study |
title_sort | potential for molecular testing for group a streptococcus to improve diagnosis and management in a high-risk population: a prospective study |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469435/ https://www.ncbi.nlm.nih.gov/pubmed/31011589 http://dx.doi.org/10.1093/ofid/ofz097 |
work_keys_str_mv | AT ralphannap potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy AT holtdeborahc potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy AT islamsharifun potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy AT osowickijoshua potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy AT carrolldavide potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy AT tongstevenyc potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy AT bowenashac potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy |